- CELG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $427.4 million.
- CELG traded 24,564 shares today in the pre-market hours as of 9:09 AM.
- CELG is up 2.5% today from yesterday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CELG with the Ticky from Trade-Ideas. See the FREE profile for CELG NOW at Trade-Ideas More details on CELG: Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. CELG has a PE ratio of 59.8. Currently there are 17 analysts that rate Celgene a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Celgene has been 5.0 million shares per day over the past 30 days. Celgene has a market cap of $91.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.00 and a short float of 1.6% with 3.41 days to cover. Shares are up 34.5% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.